Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Doses of GLPG1972 for 4 Weeks in Subjects With Osteoarthritis.
Phase of Trial: Phase I
Latest Information Update: 16 Jun 2018
At a glance
- Drugs GLPG 1972 (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Galapagos NV
- 16 Jun 2018 Results presented at the 19th Annual Congress of the European League Against Rheumatism
- 07 Jan 2018 Topline results presented in a Galapagos Media Release.
- 21 Nov 2017 Status changed from active, no longer recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History